video1.0<iframe src="https://www.loom.com/embed/829155ec51234c94929af0c8e69ba31c" frameborder="0" width="1920" height="1440" webkitallowfullscreen mozallowfullscreen allowfullscreen></iframe>14401920Loomhttps://www.loom.com14401920https://cdn.loom.com/sessions/thumbnails/829155ec51234c94929af0c8e69ba31c-ee515679f9d6ac97.gif2122.887In this presentation, I discussed the stealthy nature of Borrelia and Bartonella pathogens, highlighting the persistence of Borrelia burgdorferi in both reservoir and incidental hosts, which affects over 2 million people in the U.S. suffering from post-treatment Lyme disease. I presented evidence from our research on antibiotic efficacy, showing that combination therapies may be more effective than monotherapies in eradicating these infections. I also emphasized the need for further research into Bartonella, particularly its neurological manifestations and the challenges in diagnosing and treating co-infections. I encourage collaboration and exploration of clinical trials to investigate the efficacy of combination therapies in human subjects. Thank you for your attention, and I welcome any questions.